These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34518175)

  • 1. Graves' disease in a patient with Down syndrome: a shift from hyperthyroidism to hypothyroidism.
    Costa STB; Albino V; Peres A; Ferreira P
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34518175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of block-replace regimen in patients with autoimmune hypothyroidism converted to Graves' disease.
    Stancu AM; Alexandrescu D; Badiu C
    Hormones (Athens); 2024 Mar; 23(1):107-111. PubMed ID: 37831339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' Disease: Can It Be Cured?
    Wiersinga WM
    Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metamorphic thyroid autoimmunity in Down Syndrome: from Hashimoto's thyroiditis to Graves' disease and beyond.
    Aversa T; Valenzise M; Salerno M; Corrias A; Iughetti L; Radetti G; De Luca F; Wasniewska M
    Ital J Pediatr; 2015 Nov; 41():87. PubMed ID: 26558364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of multiple-antibody-mediated hyperthyroidism in children with Down's syndrome.
    Bhowmick SK; Grubb PH
    South Med J; 1997 Mar; 90(3):312-5. PubMed ID: 9076303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A RARE CASE OF A PATIENT WITH HYPERTHYROIDISM AFTER HYPOTHYROIDISM.
    Todorova B; Bitoska I; Muca A; Janev O; Milenkovik T
    Georgian Med News; 2023; (340-341):14-16. PubMed ID: 37805867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
    Nachum Z; Rakover Y; Weiner E; Shalev E
    Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient-specific treatment model for Graves' hyperthyroidism.
    Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
    Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies.
    Chung HK; Kim WB; Park DJ; Kohn LD; Tahara K; Cho BY
    Thyroid; 1999 Apr; 9(4):393-9. PubMed ID: 10319947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthyroidism in a population with Down syndrome (DS).
    Goday-Arno A; Cerda-Esteva M; Flores-Le-Roux JA; Chillaron-Jordan JJ; Corretger JM; Cano-Pérez JF
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):110-4. PubMed ID: 18793345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
    Washio K; Uenaka M; Tanimura K; Deguchi M; Nishida K; Fujioka K; Yamada H
    Kobe J Med Sci; 2021 Feb; 66(4):E153-E158. PubMed ID: 33994519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
    Benker G; Reinwein D; Kahaly G; Tegler L; Alexander WD; Fassbinder J; Hirche H
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):451-7. PubMed ID: 9876342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term remission following antithyroid drug withdrawal in patients with Graves' hyperthyroidism: parameters with prognostic value.
    García-Mayor RV; Álvarez-Vázquez P; Fluiters E; Valverde D; Andrade A
    Endocrine; 2019 Feb; 63(2):316-322. PubMed ID: 30334140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.